Differences in the Microbial Composition of Hemodialysis Patients Treated with and without β-Blockers

β-blockers are commonly prescribed to treat cardiovascular disease in hemodialysis patients. Beyond the pharmacological effects, β-blockers have potential impacts on gut microbiota, but no study has investigated the effect in hemodialysis patients. Hence, we aim to investigate the gut microbiota com...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Ting, Lin, Ting-Yun, Hung, Szu-Chun, Liu, Po-Yu, Hung, Wei-Chun, Tsai, Wei-Chung, Tsai, Yi-Chun, Delicano, Rachel Ann, Chuang, Yun-Shiuan, Kuo, Mei-Chuan, Chiu, Yi-Wen, Wu, Ping-Hsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002078/
https://www.ncbi.nlm.nih.gov/pubmed/33809103
http://dx.doi.org/10.3390/jpm11030198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002078/
https://www.ncbi.nlm.nih.gov/pubmed/33809103
http://dx.doi.org/10.3390/jpm11030198

Ejemplares similares